Skip to search formSkip to main contentSkip to account menu

Mirvaso

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Mirvaso is the first selective alpha2 agonist to be licensed in the UK for the management of the erythema of rosacea. Here we…